# Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural

> **NCT00509405** · PHASE3 · COMPLETED · sponsor: **Kantonsspital Baselland Bruderholz** · enrollment: 202 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** potassium citrate

## Key facts

- **NCT ID:** NCT00509405
- **Lead sponsor:** Kantonsspital Baselland Bruderholz
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2012-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509405, "Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00509405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*